Cargando…

Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: Clinical and laboratory evaluation()

Recombinant-Feline Interferon-Omega (rFeIFN-ω) is an immune-modulator licensed for use subcutaneously in Feline Immunodeficiency virus (FIV) therapy. Despite oral protocols have been suggested, little is known about such use in FIV-infected cats. This study aimed to evaluate the clinical improvement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil, S., Leal, R.O., McGahie, D., Sepúlveda, N., Duarte, A., Niza, M.M.R.E., Tavares, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111837/ https://www.ncbi.nlm.nih.gov/pubmed/24332273 http://dx.doi.org/10.1016/j.rvsc.2013.11.007

Ejemplares similares

Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega
por: Leal, Rodolfo O., et al.
Publicado: (2015)

The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome
por: Leal, Rodolfo O, et al.
Publicado: (2013)

Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter()
por: Gil, Solange, et al.
Publicado: (2013)

Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats
por: Hennet, Philippe R., et al.
Publicado: (2011)

The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives
por: Leal, Rodolfo Oliveira, et al.
Publicado: (2016)

Evaluation of a Point-of-Care Feline Immunodeficiency Virus (FIV) Test Kit (RapidSTATUS™ FIV) to Determine the FIV Status of FIV-Vaccinated and FIV-Unvaccinated Pet Cats in Australia
por: Cheang, Ashley, et al.
Publicado: (2022)

Immunomodulator expression in trophoblasts from the feline immunodeficiency virus (FIV)-infected cat
por: Scott, Veronica L, et al.
Publicado: (2011)

Feline immunodeficiency virus (FIV) env recombinants are common in natural infections
por: Bęczkowski, Paweł M, et al.
Publicado: (2014)

Enrichment Preferences of FIV-Infected and Uninfected Laboratory-Housed Cats
por: Kennedy, Claudia J., et al.
Publicado: (2018)

Feline T-cell lymphotropic lentivirus proteins; cat FIV virus used for the specific detection of FIV antibodies, production of antibodies and in vaccine; DNA sequence
Publicado: (1991)

The Molecular Biology of Feline Immunodeficiency Virus (FIV)
por: Kenyon, Julia C., et al.
Publicado: (2011)

Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV)
por: Mohammadi, Hakimeh, et al.
Publicado: (2012)

Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV)
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Clinicopathological and Epidemiological Findings in Pet Cats Naturally Infected with Feline Immunodeficiency Virus (FIV) in Australia
por: Carlton, Caroline, et al.
Publicado: (2022)

Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax(®) FIV)
por: Westman, Mark, et al.
Publicado: (2021)

Use of recombinant interferon omega in feline retrovirosis: From theory to practice
por: Doménech, Ana, et al.
Publicado: (2011)

Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Feline Immunodeficiency Virus (FIV) Neutralization: A Review
por: Hosie, Margaret J., et al.
Publicado: (2011)

Cutaneous lesions associated with feline coronavirus, FIP, and FIV
Publicado: (2006)

Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management
por: Westman, ME, et al.
Publicado: (2022)

Risk of Feline Immunodeficiency Virus (FIV) Infection in Pet Cats in Australia is Higher in Areas of Lower Socioeconomic Status
por: Tran, Vivian, et al.
Publicado: (2019)

The virus–receptor interaction in the replication of feline immunodeficiency virus (FIV)()
por: Willett, Brian J, et al.
Publicado: (2013)

Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
por: Zhang, Zeli, et al.
Publicado: (2018)

Influence of the FIV Status and Chronic Gingivitis on Feline Oral Microbiota
por: Older, Caitlin E., et al.
Publicado: (2020)

Virus–host interaction in feline immunodeficiency virus (FIV) infection
por: Taniwaki, Sueli Akemi, et al.
Publicado: (2013)

In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease
por: Moraillon, A., et al.
Publicado: (1992)

Comparative palatability of five supplements designed for cats suffering from chronic renal disease
por: Bernachon, Natalia, et al.
Publicado: (2014)

Acute phase response to Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats
por: Korman, R.M., et al.
Publicado: (2012)

European molecular epidemiology and strain diversity of feline calicivirus
por: Hou, J., et al.
Publicado: (2016)

Aberrant placental immune parameters in the feline immunodeficiency virus (FIV)-infected cat suggest virus-induced changes in T cell function
por: Chumbley, Lyndon Bart, et al.
Publicado: (2013)

Renal Alterations in Feline Immunodeficiency Virus (FIV)-Infected Cats: A Natural Model of Lentivirus-Induced Renal Disease Changes
por: Poli, Alessandro, et al.
Publicado: (2012)

Feline immunodeficiency virus (FIV) infection leads to increased incidence of feline odontoclastic resorptive lesions (FORL)
por: Hofmann-Lehmann, Regina, et al.
Publicado: (1998)

Studies on feline CD8(+) T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity
por: Hohdatsu, T., et al.
Publicado: (2000)

Comparative palatability of two veterinary dewormers (Milpro(®) and Milbemax(®)): a blinded randomised crossover cat study
por: Bernachon, N., et al.
Publicado: (2014)

Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions
por: Roelke, Melody E., et al.
Publicado: (2009)

Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors
por: Zhang, Zeli, et al.
Publicado: (2016)

Evaluation of Different Antiretroviral Drug Protocols on Naturally Infected Feline Immunodeficiency Virus (FIV) Cats in the late Phase of the Asymptomatic Stage of Infection
por: Gómez, Nélida V., et al.
Publicado: (2012)

Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: Consequences of recombinant feline interferon-ω administration
por: Paltrinieri, Saverio, et al.
Publicado: (2007)

Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
por: Ishida, T, et al.
Publicado: (2004)

Interferon-γ in the serum and effusions of cats with feline coronavirus infection
por: Giordano, Alessia, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ag83kine6b0rnun1qfuimilvmj